Sanofi SA vs United Microelectronics Corp — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while United Microelectronics Corp trades at $21.12 (market cap $51.00B). The key difference: Sanofi SA is far larger — about 2.1× United Microelectronics Corp's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | UMC | |
|---|---|---|
Market Cap | $104.83B | $51.00B |
Sector | Health | Technology |
52-Week High | $52.34 | $28.02 |
52-Week Low | $41.33 | $6.58 |
Enterprise Value | $121.32B | $48.57B |
Dividend Yield | 5.5% | 2.03% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →